Human papillomavirus (HPV) is causally associated with 5% of cancers, including cancers
of the cervix, penis, vulva, vagina, anus and oropharynx. The most carcinogenic HPV is HPV …

Background Understanding the proportion of invasive cervical cancer (ICC) caused by
different human papillomavirus (HPV) genotypes can inform primary (ie, vaccination) and …

Squamous cell carcinoma of the anus (SCCA) is caused by HPV, and is elevated in persons
living with HIV (PLWHIV). We aimed to estimate sex‐and HIV‐stratified SCCA burden at a …

To support a strategy to eliminate cervical cancer as a public health problem, the World
Health Organisation (WHO) reviewed its guidelines for screening and treatment of cervical …

Background Old age is an important risk factor for developing cancer, but few data exist on
this association in people with human immunodeficiency virus (HIV, PWH) in sub-Saharan …

Immunotherapy is an emerging method for the treatment of cervical cancer and is more
effective than surgery and radiotherapy, especially for recurrent cervical cancer. However …

Abstract In 2020, over 34 000 cases of Kaposi sarcoma (KS) were estimated globally, all
attributable to KS herpesvirus (KSHV). Prior to the HIV epidemic, KS already existed in …

The burden of cervical cancer is disproportionately distributed globally, with the vast majority
of cases occurring in low-and middle-income countries. Women with human …

Background Cervical cancer screening uptake remains low despite being a critical
prevention method for adult women living with HIV (WLHIV). These women experience …

Abstract Human papillomaviruses (HPV) cause 99% of all cervical cancer cases globally,
with the high-risk genotypes 16 and 18 causing at least 70% of these cases. An estimated …